PPA Literature Relevance To Ephedra Supplement Safety Questioned
This article was originally published in The Tan Sheet
Executive Summary
Structural and pharmacological differences between phenylpropanolamine and other ephedrine alkaloids negate FDA's heavy reliance on PPA literature in its analysis of adverse health effects caused by dietary supplements, industry consultants asserted at an Aug. 8-9 Public Health Service meeting in Washington, D.C.